Estropipate

Catalog No. A17579

Estropipate is a form of estrogen, an estrogen receptor agonist. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics, and treatment of prostate cancer and prevention of osteoporosis.

Technical details

Catalog Num	A17579
M. Wt	436.56
Formula	C22H32N2O5S
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	7280-37-7
Synonyms	Estropipate; Piperazine estrone sulfate; Harmogen; Ogen; Piperazine estronesulfate;
SMILES	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O

Biological Activity

Solubility *

In vitro	DMSO	85 mg/mL (194.7 mM)
	Water
	Ethanol
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	22.91 mL	114.53 mL	229.06 mL
0.5 mM	4.58 mL	22.91 mL	45.81 mL
1 mM	2.29 mL	11.45 mL	22.91 mL
5 mM	0.46 mL	2.29 mL	4.58 mL

*The above data is based on the productmolecular weight 436.56. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience

Estropipate

Technical details

Biological Activity

Solubility *

Preparing Stock Solutions